Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 267630, 12 pages
http://dx.doi.org/10.1155/2013/267630
Clinical Study

Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade

1Department of Medicine, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, 160 Pu Jian Avenue, Shanghai 200127, China
2Department of Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, 197 Ruijiner Road, Shanghai 200025, China
3Department of Gastroenterology, Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Inflammatory Bowel Disease Research Center, 160 Pu Jian Avenue, Shanghai 200127, China

Received 2 August 2013; Accepted 7 October 2013

Academic Editor: D. Fan

Copyright © 2013 Junjie Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Abraham and J. H. Cho, “Inflammatory bowel disease,” New England Journal of Medicine, vol. 361, no. 21, pp. 2066–2078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Satsangi, M. S. Silverberg, S. Vermeire, and J.-F. Colombel, “The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications,” Gut, vol. 55, no. 6, pp. 749–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Mudter, “What's new about inflammatory bowel diseases in 2011,” World Journal of Gastroenterology, vol. 17, no. 27, article 3177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review,” Gastroenterology, vol. 142, no. 1, pp. 46–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. D. Lovasz, P. A. Golovics, Z. Vegh, and P. L. Lakatos, “New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe,” Digestive and Liver Disease, vol. 45, no. 4, pp. 269–276, 2013. View at Google Scholar
  6. C. N. Bernstein, “Epidemiologic clues to inflammatory bowel disease,” Current Gastroenterology Reports, vol. 12, no. 6, pp. 495–501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. V. Loftus Jr., “Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences,” Gastroenterology, vol. 126, no. 6, pp. 1504–1517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. F. Wang, Q. Ouyang, and R. W. Hu, “Progression of inflammatory bowel disease in China,” Journal of Digestive Diseases, vol. 11, no. 2, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. N. Bernstein, T. Longobardi, G. Finlayson, and J. F. Blanchard, “Direct medical cost of managing IBD patients: a Canadian population-based study,” Inflammatory Bowel Diseases, vol. 18, pp. 1498–1508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Kappelman, S. L. Rifas-Shiman, C. Q. Porter et al., “Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults,” Gastroenterology, vol. 135, no. 6, pp. 1907–1913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Odes, H. Vardi, M. Friger et al., “Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation,” Gastroenterology, vol. 131, no. 3, pp. 719–728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bassi, S. Dodd, P. Williamson, and K. Bodger, “Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study,” Gut, vol. 53, no. 10, pp. 1471–1478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Bodger, “Cost effectiveness of treatments for inflammatory bowel disease,” PharmacoEconomics, vol. 29, no. 5, pp. 387–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. van der Valk, M. J. Mangen, M. Leenders et al., “Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF? therapy: results from the COIN study,” Gut, 2012. View at Google Scholar
  15. R. Karagozian, R. S. Johannes, X. Sun, and R. Burakoff, “Increased mortality and length of stay among patients with inflammatory bowel disease and hospital-acquired infections,” Clinical Gastroenterology and Hepatology, vol. 8, no. 11, pp. 961–965, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Zhang, Q. Zhu, X. Zhang et al., “The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China,” PLoS ONE, vol. 7, Article ID e44391, 2012. View at Google Scholar
  17. V. N. Joish, G. Donaldson, W. Stockdale et al., “The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database,” Current Medical Research and Opinion, vol. 21, no. 4, pp. 535–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Lakatos, L. S. Kiss, G. David et al., “Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006,” Inflammatory Bowel Diseases, vol. 17, no. 12, pp. 2558–2565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Prideaux, M. A. Kamm, P. P. De Cruz, F. K. Chan, and S. C. Ng, “Inflammatory bowel disease in Asia: a systematic review,” Journal of Gastroenterology and Hepatology, vol. 27, pp. 1266–1280, 2012. View at Google Scholar
  20. L. Jiang, B. Xia, J. Li et al., “Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan City, Central China,” Inflammatory Bowel Diseases, vol. 12, no. 3, pp. 212–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-W. Wang, F. Ji, W.-J. Teng, X.-G. Yuan, and X.-M. Ye, “Risk factors and gene polymorphisms of inflammatory bowel disease in population of Zhejiang, China,” World Journal of Gastroenterology, vol. 17, no. 1, pp. 118–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Leighton, “The role of endoscopic imaging of the small bowel in clinical practice,” American Journal of Gastroenterology, vol. 106, no. 1, pp. 27–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. E. Dye, R. R. Gaffney, T. M. Dykes, and M. T. Moyer, “Endoscopic and radiographic evaluation of the small bowel in 2012,” American Journal of Medicine, vol. 125, pp. 1228.e1–1228.e12, 2012. View at Google Scholar
  24. X.-L. Jiang and H.-F. Cui, “An analysis of 10218 ulcerative colitis cases in China,” World Journal of Gastroenterology, vol. 8, no. 1, pp. 158–161, 2002. View at Google Scholar · View at Scopus
  25. D. C. Baumgart and W. J. Sandborn, “Inflammatory bowel disease: clinical aspects and established and evolving therapies,” The Lancet, vol. 369, no. 9573, pp. 1641–1657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. F. Frøslie, J. Jahnsen, B. A. Moum, and M. H. Vatn, “Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort,” Gastroenterology, vol. 133, no. 2, pp. 412–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Simpson and K. A. Papadakis, “Endoscopic evaluation of patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 14, no. 9, pp. 1287–1297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Dave and E. V. Loftus Jr., “Mucosal healing in inflammatory bowel disease—a true paradigm of success?” Gastroenterology and Hepatology, vol. 8, no. 1, pp. 29–38, 2012. View at Google Scholar · View at Scopus
  29. T. Jess, L. Riis, I. Vind et al., “Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark,” Inflammatory Bowel Diseases, vol. 13, no. 4, pp. 481–489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Subasinghe, N. M. M. Nawarathna, and D. N. Samarasekera, “Disease characteristics of inflammatory bowel disease (IBD),” Journal of Gastrointestinal Surgery, vol. 15, no. 9, pp. 1562–1567, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Jakobsen, A. Paerregaard, P. Munkholm et al., “Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007–2009,” Inflammatory Bowel Diseases, vol. 17, no. 12, pp. 2541–2550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. L. E. Targownik, H. Singh, Z. Nugent, and C. N. Bernstein, “The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort,” American Journal of Gastroenterology, vol. 107, pp. 1228–1235, 2012. View at Google Scholar
  33. X. Gao, R. P. Yang, M. H. Chen et al., “Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease,” Scandinavian Journal of Gastroenterology, vol. 47, pp. 1181–1191, 2012. View at Google Scholar
  34. E. Stranges, N. Kowlessar, and A. Elixhauser, “Components of Growth in Inpatient Hospital Costs, 1997–2009: Statistical Brief #123,” Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Agency for Health Care Policy and Research (US), Rockville, MD, USA, 2011.
  35. J. Simó Miñana, J. Gérvas Camacho, M. Seguí Díaz, R.D. Pablo González, and J. Domínguez Velázquez, “Health care expenditure in Spain compared with developed Europe, 1985-2001. The Spanish primary health care, the European Cinderella,” Aten Primaria, vol. 34, pp. 472–481, 2004. View at Google Scholar
  36. D. Simonet, “Healthcare reforms and cost reduction strategies in Europe: the cases of Germany, UK, Switzerland, Italy and France,” International Journal of Health Care Quality Assurance, vol. 23, no. 5, pp. 470–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. R. Orszag and E. J. Emanuel, “Health care reform and cost control,” New England Journal of Medicine, vol. 363, no. 7, pp. 601–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. U. Himmelstein and S. Woolhandler, “Cost control in a parallel universe: medicare spending in the United States and Canada,” Archives of Internal Medicine, vol. 29, pp. 1–2, 2012. View at Google Scholar
  39. China National Health Economics Institute. China National Health Accounts Report, 2008. Government of the People's Republic of China, 2009.
  40. “Health insurance systems in China: a briefing note,” World Health Report 37, World Health Organization, Geneva, Switzerland, 2011.
  41. Communist Party of China Central Committee; State Council, “Opinions of the Communist Party of China Central Committee and the State Council on Deepening the Health Care System Reform,” Government of the People's Republic of China.